MT1988
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MT1988, covering 2025-04-17 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis [Phase 1, Phase 2]